BTIG Research Begins Coverage on BrightSpring Health Services (NASDAQ:BTSG)

Research analysts at BTIG Research began coverage on shares of BrightSpring Health Services (NASDAQ:BTSGGet Free Report) in a note issued to investors on Friday, Briefing.com reports. The firm set a “buy” rating and a $15.00 price target on the stock. BTIG Research’s price objective indicates a potential upside of 43.95% from the stock’s previous close.

BTSG has been the subject of a number of other research reports. Wells Fargo & Company boosted their target price on BrightSpring Health Services from $15.00 to $16.00 and gave the company an “overweight” rating in a research note on Monday, May 6th. The Goldman Sachs Group dropped their price target on shares of BrightSpring Health Services from $26.00 to $23.00 and set a “buy” rating for the company in a research report on Monday, March 4th. HSBC started coverage on shares of BrightSpring Health Services in a research report on Wednesday, March 6th. They issued a “buy” rating and a $13.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of BrightSpring Health Services from a “hold” rating to a “buy” rating and set a $11.50 target price for the company in a report on Tuesday, February 27th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, BrightSpring Health Services has a consensus rating of “Buy” and an average price target of $15.77.

Get Our Latest Stock Report on BTSG

BrightSpring Health Services Stock Performance

NASDAQ:BTSG opened at $10.42 on Friday. The stock has a 50 day moving average price of $11.01. The company has a quick ratio of 0.96, a current ratio of 1.26 and a debt-to-equity ratio of 1.62. BrightSpring Health Services has a 1-year low of $7.85 and a 1-year high of $12.21.

BrightSpring Health Services (NASDAQ:BTSGGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.06. The business had revenue of $2.58 billion during the quarter, compared to the consensus estimate of $2.31 billion. The company’s revenue was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. Equities analysts predict that BrightSpring Health Services will post 0.59 EPS for the current year.

Institutional Investors Weigh In On BrightSpring Health Services

Several hedge funds have recently made changes to their positions in BTSG. Farallon Capital Management LLC bought a new position in BrightSpring Health Services in the first quarter worth $239,000. 8 Knots Management LLC purchased a new position in BrightSpring Health Services during the 1st quarter valued at about $67,678,000. Silvercrest Asset Management Group LLC bought a new stake in BrightSpring Health Services during the first quarter worth about $14,179,000. Kohlberg Kravis Roberts & Co. L.P. purchased a new stake in BrightSpring Health Services in the first quarter worth about $884,166,000. Finally, Blackstone Inc. bought a new position in shares of BrightSpring Health Services during the first quarter valued at approximately $5,435,000.

BrightSpring Health Services Company Profile

(Get Free Report)

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Recommended Stories

Analyst Recommendations for BrightSpring Health Services (NASDAQ:BTSG)

Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.